Comparison of risedronate versus placebo in preventing anastrozole-induced bone loss in women at high risk of developing breast cancer with osteopenia

Sestak, I., Blake, G.M., Patel, R. et al. (3 more authors) (2019) Comparison of risedronate versus placebo in preventing anastrozole-induced bone loss in women at high risk of developing breast cancer with osteopenia. Bone, 124. pp. 83-88. ISSN 8756-3282

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2019 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/BY/4.0/).

Keywords: Osteopenia; Bone mineral density; Anastrozole; Risedronate; Bone marker; Breast cancer risk
Dates:
  • Accepted: 24 April 2019
  • Published (online): 24 April 2019
  • Published: July 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Funding Information:
Funder
Grant number
MEDICAL RESEARCH COUNCIL
nan
Depositing User: Symplectic Sheffield
Date Deposited: 03 Mar 2021 17:13
Last Modified: 05 Mar 2021 05:26
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: 10.1016/j.bone.2019.04.016
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics